Literature DB >> 4214633

Glutaraldehyde-pollen-tyrosine: clinical and immunological studies.

S G Johansson, A C Miller, N Mullan, B G Overell, E C Tees, A Wheeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4214633     DOI： 10.1111/j.1365-2222.1974.tb01383.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN： 0009-9090


× No keyword cloud information.
  7 in total

1.  Isotype-selective abrogation of established IgE responses.

Authors:  K T HayGlass; W Stefura
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 2.  Allergen injection immunotherapy for seasonal allergic rhinitis.

Authors:  M A Calderon; B Alves; M Jacobson; B Hurwitz; A Sheikh; S Durham
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Immunotherapy in respiratory allergy.

Authors:  R J Davies
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

4.  Antigen-specific modulation of murine IgE and IgG2a responses with glutaraldehyde-polymerized allergen is independent of MHC haplotype and Igh allotype.

Authors:  K T Hayglass; W Stefura
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

5.  Influence of preseasonal treatment with L-tyrosine-adsorbed allergoids on IgE-mediated histamine release from basophils of children suffering from allergic diseases.

Authors:  F Wegner; A Fenkes; E A Stemmann; D Reinhardt
Journal:  Agents Actions       Date:  1981-04

6.  Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D-lysine.

Authors:  T P King; L Kochoumian; N Chiorazzi
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

7.  Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo.

Authors:  X Yang; R S Gieni; T R Mosmann; K T HayGlass
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.